{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-02T12:26:12.636662+00:00",
  "news": [
    {
      "title": "1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPRU1LQUJsWDBlTHpDTFU3ZFVYblkyZnBQZXNoMV9BOUNURng2a3BFbmxpejdaU29hcmN6VFlfaHdEZmRHZ21iaHhxWm83ZXBwNUpGajlNOGpZT1RMcDYwWlVBOW0wVFMySzBMdTJtRlh5QVQ2anR6czFvU2ZGMFBGN2dIeXpYUDRPTHZmY0U2ZjloQzkzODBz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxPRU1LQUJsWDBlTHpDTFU3ZFVYblkyZnBQZXNoMV9BOUNURng2a3BFbmxpejdaU29hcmN6VFlfaHdEZmRHZ21iaHhxWm83ZXBwNUpGajlNOGpZT1RMcDYwWlVBOW0wVFMySzBMdTJtRlh5QVQ2anR6czFvU2ZGMFBGN2dIeXpYUDRPTHZmY0U2ZjloQzkzODBz?oc=5\" target=\"_blank\">1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-17T08:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - MSN",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPM0R0dGxYSzgzTklpa0d0OUotV2ItdVp4RTd0ZS0waGpqVHJyejdvZzM3MHRBSjh0bFUtci03dHhkRTlfdXdaSWE1RkFjRnZzalBCM1BYLUdIdExraFJJckM3bzNnM1NmeW1CVnU2a1kybDE5ell5WTdkbGt0c296Tm9QQm9qcGtLRlBqR21vUk5zQ1ZjNldPaXctOUZuZktfZ1hvNEFEMWhPWkROXzJZ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxPM0R0dGxYSzgzTklpa0d0OUotV2ItdVp4RTd0ZS0waGpqVHJyejdvZzM3MHRBSjh0bFUtci03dHhkRTlfdXdaSWE1RkFjRnZzalBCM1BYLUdIdExraFJJckM3bzNnM1NmeW1CVnU2a1kybDE5ell5WTdkbGt0c296Tm9QQm9qcGtLRlBqR21vUk5zQ1ZjNldPaXctOUZuZktfZ1hvNEFEMWhPWkROXzJZ?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-12-01T15:00:18+00:00",
      "source": "MSN"
    },
    {
      "title": "What Do Analysts Think About Vertex Pharmaceuticals (VRTX)? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPY28wcFBuVkpjdnh5WE1vNjlDUVB0Rlo4LTdWUDFJVVNIUTFMZUV1TC1XWi1hZmxTVDNCMGwwU003NDN4R0tUbjdGVWZXaHRXX1ZsNWJLbURTU2JuVkJTNGcxOVp5b216ZEZFRTJsc1BsWXUxVGN2Z2ZTVmhhcWs5OTFfRkJSS3VkTjVnZHBtYU9lUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxPY28wcFBuVkpjdnh5WE1vNjlDUVB0Rlo4LTdWUDFJVVNIUTFMZUV1TC1XWi1hZmxTVDNCMGwwU003NDN4R0tUbjdGVWZXaHRXX1ZsNWJLbURTU2JuVkJTNGcxOVp5b216ZEZFRTJsc1BsWXUxVGN2Z2ZTVmhhcWs5OTFfRkJSS3VkTjVnZHBtYU9lUQ?oc=5\" target=\"_blank\">What Do Analysts Think About Vertex Pharmaceuticals (VRTX)?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-26T19:49:57+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock - sharewise.com",
      "link": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPR0R2NjVGS2NlTzFqWnQ4N1hRNGljU0pBYXo3Sk1ZekRpekYzbmtDN0ItbG9KN29ZdTdILW1ZcnNZVG5UZkVBT2pkd0VneEtJcFBKMWdSMVIxTkx5SjNtZ3J3cEppamRGbWJGUVU1OWRBZXZwV3Nkblp1NGZkRVRwaVdUb1RSQnBWMVF2aXJET0g4dW1RV0h0RzJJTTY4SVpMREQydmhuNGdGZXJKdFpTNVZWNTFJWWo3Rm45NzdTLW1YWUczMThvdVVZMWREU2thRDBTTnJwVFRaNW5wMjd2cW1ic1JEOXFJdkFn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPR0R2NjVGS2NlTzFqWnQ4N1hRNGljU0pBYXo3Sk1ZekRpekYzbmtDN0ItbG9KN29ZdTdILW1ZcnNZVG5UZkVBT2pkd0VneEtJcFBKMWdSMVIxTkx5SjNtZ3J3cEppamRGbWJGUVU1OWRBZXZwV3Nkblp1NGZkRVRwaVdUb1RSQnBWMVF2aXJET0g4dW1RV0h0RzJJTTY4SVpMREQydmhuNGdGZXJKdFpTNVZWNTFJWWo3Rm45NzdTLW1YWUczMThvdVVZMWREU2thRDBTTnJwVFRaNW5wMjd2cW1ic1JEOXFJdkFn?oc=5\" target=\"_blank\">Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">sharewise.com</font>",
      "published": "2025-12-02T03:22:07+00:00",
      "source": "sharewise.com"
    },
    {
      "title": "Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq? - Barchart.com",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxObm52WjRCZDVNMXdGdVMwbktJVjduSFNqQzF5TWltQWtqdDZnQVlKX0xoRHZtR1ZMcld2YVlqb21BSlFXWEE0aGFtQ204QjFoUHR0d3dOTjh0YzlibmxfLXZacHRHQ1hfelY4MVU4b1NtWjdnNWQzclluSHJNam1KXzh1SmsyMDdXWGJsTHhqNnBsb3UwdzNzMjlERVZQemZvb3J2RmF3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxObm52WjRCZDVNMXdGdVMwbktJVjduSFNqQzF5TWltQWtqdDZnQVlKX0xoRHZtR1ZMcld2YVlqb21BSlFXWEE0aGFtQ204QjFoUHR0d3dOTjh0YzlibmxfLXZacHRHQ1hfelY4MVU4b1NtWjdnNWQzclluSHJNam1KXzh1SmsyMDdXWGJsTHhqNnBsb3UwdzNzMjlERVZQemZvb3J2RmF3?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barchart.com</font>",
      "published": "2025-11-28T11:25:04+00:00",
      "source": "Barchart.com"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Vertex Pharmaceuticals: A Diversification Play Poised to Join the Top 10 Global Healthcare Giants - NAI500",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObUVzNEdUTVFJOHUyc1prVnE5Y0h6WEExYTVoREJjSFU3dDI0NkUwWW5XRVlUcVBlamZiTjJpbmhOaXNqcFNRTUZueWRqVmMtNFFQMnZ5SGhJeTNkQkljRHFLYkpXc1hqSERlaVA2SUZNUVBFbjNfa205MFVtdDhwYW9jY2htZ2ZWWWdGNENLNXMyWTRoQTlnbGphb1B2di1iVDdZV3l4ZVVyMmxram1BSXIyRU4yVkQ4Z2ZhNXpnWGtDRThHeFFucQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxObUVzNEdUTVFJOHUyc1prVnE5Y0h6WEExYTVoREJjSFU3dDI0NkUwWW5XRVlUcVBlamZiTjJpbmhOaXNqcFNRTUZueWRqVmMtNFFQMnZ5SGhJeTNkQkljRHFLYkpXc1hqSERlaVA2SUZNUVBFbjNfa205MFVtdDhwYW9jY2htZ2ZWWWdGNENLNXMyWTRoQTlnbGphb1B2di1iVDdZV3l4ZVVyMmxram1BSXIyRU4yVkQ4Z2ZhNXpnWGtDRThHeFFucQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Diversification Play Poised to Join the Top 10 Global Healthcare Giants</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NAI500</font>",
      "published": "2025-11-28T05:15:49+00:00",
      "source": "NAI500"
    },
    {
      "title": "A Look at Vertex Pharmaceuticals’s Valuation After Discontinuing Experimental Pain Drug Development - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Vertex Pharmaceuticals’s Valuation After Discontinuing Experimental Pain Drug Development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-26T04:46:35+00:00",
      "source": "simplywall.st"
    }
  ],
  "product_launches": [
    {
      "title": "Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQd0g4T3hlT04wT2E3VkRHZHk2cFVHQmZOamlLYm9oTE1oeWsyQWVqbHlycDhiS2Vva2ZnRzluYmJuWEJ1TjdubDZDa1JwVmxsMU4yWjlfTzlsazZwV3VQdFgwbkJBakJjUmdRb1lsUGZPbFBCMXZwaEN3SXNfdGFWZ1VKcnpjZWE2c0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQd0g4T3hlT04wT2E3VkRHZHk2cFVHQmZOamlLYm9oTE1oeWsyQWVqbHlycDhiS2Vva2ZnRzluYmJuWEJ1TjdubDZDa1JwVmxsMU4yWjlfTzlsazZwV3VQdFgwbkJBakJjUmdRb1lsUGZPbFBCMXZwaEN3SXNfdGFWZ1VKcnpjZWE2c0E?oc=5\" target=\"_blank\">Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-27T16:12:37+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-01",
      "close": 425.6000061035156
    },
    "history": [
      {
        "date": "2025-11-20",
        "close": 422.32000732421875
      },
      {
        "date": "2025-11-21",
        "close": 426.760009765625
      },
      {
        "date": "2025-11-24",
        "close": 424.0
      },
      {
        "date": "2025-11-25",
        "close": 429.82000732421875
      },
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      },
      {
        "date": "2025-11-28",
        "close": 433.6099853515625
      },
      {
        "date": "2025-12-01",
        "close": 425.6000061035156
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}